Gene: KCNJ8
Official Full Name: potassium inwardly rectifying channel subfamily J member 8provided by HGNC
Gene Summary: Potassium channels are present in most mammalian cells, where they participate in a wide range of physiologic responses. The protein encoded by this gene is an integral membrane protein and inward-rectifier type potassium channel. The encoded protein, which has a greater tendency to allow potassium to flow into a cell rather than out of a cell, is controlled by G-proteins. Defects in this gene may be a cause of J-wave syndromes and sudden infant death syndrome (SIDS). [provided by RefSeq, May 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07482 | KCNJ8 Knockout cell line (HEK293) | Human | KCNJ8 | 1:3~1:6 | Negative | Online Inquiry |
KO07483 | KCNJ8 Knockout cell line (A549) | Human | KCNJ8 | 1:3~1:4 | Negative | Online Inquiry |
KCNJ8 Gene Knockout Cell Lines are specialized cellular models specifically engineered to lack the KCNJ8 gene, which encodes for the ATP-sensitive potassium ion channel subunit Kir6.1. These cell lines serve as vital tools for studying the physiological roles of KCNJ8, particularly in the context of insulin secretion and cardiac function. By removing the influence of this gene, researchers can investigate the downstream effects and compensatory mechanisms that occur in its absence, providing critical insights into various pathophysiological conditions.
The key functions of these knockout cell lines involve the modulation of cellular excitability and metabolic pathways. In pancreatic beta cells, KCNJ8 plays a significant role in controlling insulin release, thus affecting glucose homeostasis. Investigating these knockout cell lines allows for the dissection of KCNJ8's involvement in processes such as cellular depolarization and ion homeostasis, wherein secondary pathways can be analyzed in response to varying glucose levels.
Scientifically, KCNJ8 gene knockout cell lines hold considerable importance in both research and clinical contexts, particularly in diabetes and cardiovascular disease studies. They provide researchers with a powerful platform to evaluate drug responses, investigate metabolic disorders, and explore potential therapeutic strategies targeting ion channel dysregulation. Additionally, these cell lines can facilitate high-throughput screening methods, enabling efficient identification of novel compounds for further development.
What sets KCNJ8 gene knockout cell lines apart from traditional models is their specific genetic modification, which allows for unambiguous observation of KCNJ8's contributions to cellular function without the interference of compensatory mechanisms present in wild-type cells. Their versatility and robustness make them an indispensable resource for researchers aiming for translational results that can inform clinical therapeutic strategies.
Investing in KCNJ8 gene knockout cell lines is essential for any researcher or clinician focused on delineating the complexities of potassium channel dynamics. These unique models not only enhance experimental consistency but also pave the way for breakthroughs in understanding and treating conditions linked to potassium channel dysfunction. Our company prides itself on delivering high-quality biological products that empower the scientific community, supported by cutting-edge technologies and a commitment to excellence in cell line development.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.